Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2 (ETA-TV)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02877732
Recruitment Status : Terminated (The funding sponsor elected to terminate the study.)
First Posted : August 24, 2016
Results First Posted : April 30, 2018
Last Update Posted : May 30, 2018
Sponsor:
Collaborators:
Brain Trauma Foundation
United States Department of Defense
Food and Drug Administration (FDA)
U.S. Army Medical Research and Development Command
Department of Health and Human Services
Information provided by (Responsible Party):
Jamshid Ghajar, Stanford University

Brief Summary:
This is a prospective multi-center cohort feasibility and exploratory study.

Condition or disease Intervention/treatment Phase
Eye-tracking Device: EYE-SYNC eye-tracking Other: SCAT-3 subtests Other: DEM Other: Simple Reaction Time subtest of ANAM-SRT Other: Level of Alertnesss Not Applicable

Detailed Description:
Investigators propose to prospectively study a cohort of 18-25-year-old athletes to establish the reliability of EYE-SYNC data and the utility of the EYE-SYNC eye-tracking device as a sideline concussion assessment tool. The clinical research study will be conducted to 1) determine if eye-tracking, assessed on the sideline by EYE-SYNC eye-tracking device, is a potential marker of injury that can be used in conjunction with other sideline evaluations to inform decisions regarding removal of athletes from play and 2) to use the EYE-SYNC goggle data as a post- injury recovery monitor.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 12 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2
Study Start Date : July 2016
Actual Primary Completion Date : April 2017
Actual Study Completion Date : April 2017

Arm Intervention/treatment
Experimental: Concussed Subject
EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM. Investigators will be collecting medical history and demographics from each subject.
Device: EYE-SYNC eye-tracking
The EYE-SYNC® portable eye-tracking system. The eye tracker is a handheld isolated display environment with embedded eye tracking sensors. The eye tracker is connected to a high-performance Windows tablet though a customized docking station. Included accessories with EYE-SYNC are a U.S. tablet power supply adapter and disposable sanitary masks. Participants are asked to follow a dot with their eyes, as the dot moves on the screen of the EYE-SYNC device.

Other: SCAT-3 subtests
Following subtests of SCAT-3 will be administered to the participant: Symptom, Balance, Orientation and Immediate memory
Other Name: Sport Concussion Assessment Tool

Other: DEM
Participant will be asked to read list of numbers out loud from a card
Other Name: Developmental Eye Movement

Other: Simple Reaction Time subtest of ANAM-SRT
Participants will perform Simple Reaction Time sub-test of ANAM-SRT test. They will be asked to click the mouse button every time they see an asterisk on the screen. Participants will perform ANAM-SRT 1 and ANAM-SRT 2 in this study.
Other Name: Automated Neuropsychological Assessment Metrics

Other: Level of Alertnesss
Participants will answer questions. This assessment is to assess their alertness level.

Active Comparator: Control Subject
EYE-SYNC eye-tracking device, Level of Alertness, SCAT-3 subtests (Symptom, Immediate memory, Balance and Orientation), Simple Reaction Time subtest of ANAM-SRT and DEM. Investigators will be collecting medical history and demographics from each subject.
Device: EYE-SYNC eye-tracking
The EYE-SYNC® portable eye-tracking system. The eye tracker is a handheld isolated display environment with embedded eye tracking sensors. The eye tracker is connected to a high-performance Windows tablet though a customized docking station. Included accessories with EYE-SYNC are a U.S. tablet power supply adapter and disposable sanitary masks. Participants are asked to follow a dot with their eyes, as the dot moves on the screen of the EYE-SYNC device.

Other: SCAT-3 subtests
Following subtests of SCAT-3 will be administered to the participant: Symptom, Balance, Orientation and Immediate memory
Other Name: Sport Concussion Assessment Tool

Other: DEM
Participant will be asked to read list of numbers out loud from a card
Other Name: Developmental Eye Movement

Other: Simple Reaction Time subtest of ANAM-SRT
Participants will perform Simple Reaction Time sub-test of ANAM-SRT test. They will be asked to click the mouse button every time they see an asterisk on the screen. Participants will perform ANAM-SRT 1 and ANAM-SRT 2 in this study.
Other Name: Automated Neuropsychological Assessment Metrics

Other: Level of Alertnesss
Participants will answer questions. This assessment is to assess their alertness level.




Primary Outcome Measures :
  1. Changes in the Measurement of EYE-SYNC Data Immediately After Concussive Event, 2 Days, 7 Days and 14 Days Post Concussive Event. [ Time Frame: Immediate post impact, 2 days, 7 days and 14 days post impact. ]
    The EYE-SYNC test will be performed immediately after an impact, 2 days, 7 days and 14 days post impact. The movement of eye will be tracked using EYE-SYNC. The data will be recorded in a surface tablet connected to EYE-SYNC.

  2. Reliability of EYE-SYNC Data [ Time Frame: Immediate post impact, 2 days, 7 days and 14 days post impact. ]
    The integrity will be analyzed based on the score obtained from EYE-SYNC device.

  3. Integrity of EYE-SYNC Data [ Time Frame: Immediate post impact, 2 days, 7 days and 14 days post impact. ]
    The reliability will be analyzed based on the score obtained from EYE-SYNC.


Secondary Outcome Measures :
  1. Compare Sport Concussion Assessment Tool (SCAT-3) Test and EYE-SYNC Score [ Time Frame: Immediate post impact, 2 days, 7 days and 14 days post impact. ]
    The SCAT-3 result and EYE-SYNC score will be compared.

  2. Compare ANAM-SRT Test and EYE-SYNC Score [ Time Frame: Immediate post impact, 2 days, 7 days and 14 days post impact. ]
    The Automated Neuropsychological Assessment Metrics-Simple Reaction Time (ANAM-SRT) evaluation and EYE-SYNC score will be compared.

  3. Compare DEM Test and EYE-SYNC Score [ Time Frame: Immediate post impact, 2 days, 7 days and 14 days post impact. ]
    The Developmental Eye Movement (DEM) assessment and EYE-SYNC score will be compared.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 25 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Both CCS and CTR must meet the following 3 criteria:

  • Athletes between the age of 18- 25-years-old.
  • 20/30 or better eyesight (corrected vision allowed).
  • English fluency.

Control Subject:

• Control Subject (CTR) - a teammate of the concussed subject who did not experience impact but who was actively participating in the same sport and session along with the injured teammate at the time of injury

Concussed Subject:

Concussed Subject (CCS) - those who experience impact where concussion is highly suspected as evidenced by impairment in any of the SCAT-3 Domains: Symptoms, Physical Signs, Immediate Memory and Orientation. An Injured Athlete is concussed if he/she is FAIL on the Physical Signs, Score = 0 on the Orientation or Scoring below the cutoff scores on the Symptom Checklist and/or Immediate memory SCAT-3 domains.

A) Symptoms: Rating of 2 or higher on any of the following items:

  1. Headaches
  2. Nausea or Vomiting
  3. Dizziness
  4. Balance Problems
  5. Blurred Vision
  6. Feeling Slowed Down
  7. Feeling like "in a fog"
  8. "Don't feel right"

B) Physical Signs:

Balance (Leg Stances): Number of Error(s) on any of the following 7 subtests classifies a subject as concussed.

I. Double Leg Stance: At least 3 errors II. Single Leg Stance: At least 3 errors with either dominant or non-dominant foot III. Tandem Stance: At least 3 errors or more.

Balance (Tandem Gait): FAIL on at least 2 of 4 trials:

I. FAIL per trial: more than 14 seconds to complete a trial II. FAIL per trial, if one or more of the following errors are made

  1. If step off the line;
  2. Separation between heel and toe
  3. Touch/grab the examiner or an object

D) Orientation: Score = 0 on any of the following 5 items Date: Score = 0 (any date different from current) Month: Score = 0 (any month different from current) Day of the week: Score = 0 (any different from current) Year: Score = 0 (any different from current) Time: Score = 0 AND answer is MORE than + or - 1 hour apart from the correct time.

E) Immediate Memory Recall Total Score = less than 13 words recalled.

Exclusion Criteria:

  • Clinical diagnosis of a neurological condition including the following: Stroke, Multiple Sclerosis, Epilepsy, Brain Tumor/Cancer, Nystagmus and/or Other major neurological condition.
  • Clinical diagnosis of any of the following eye-sight abnormalities: Uncorrected Amblyopia, Uncorrected Myopia, Uncorrected Presbyopia, Uncorrected Farsightedness, or Uncorrected Astigmatism.
  • Psychiatric history with any of the following:

    1. Clinical diagnosis of a psychotic disorder, bipolar disorder - lifetime
    2. Clinical diagnosis of ADHD or ADD - Lifetime
    3. Clinical diagnosis of major depressive disorder - within last year
    4. Clinical diagnosis of substance abuse disorder - within last year
    5. Clinical diagnosis of major anxiety disorder - within last year

      MEDICATION

    6. Requires use of a psychotropic medication.
  • Cannot have participated previously in any of the ETA-TV study visits (for instance, a subject that has completed any study visit as a control subject cannot participate as a concussed subject at a later time point).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02877732


Locations
Layout table for location information
United States, California
University of Southern California
Los Angeles, California, United States, 90089
University of California Santa Barbara
Santa Barbara, California, United States, 93106
United States, Oregon
Oregon State University
Corvallis, Oregon, United States, 97331
United States, Utah
University of Utah
Salt Lake City, Utah, United States, 84112
Sponsors and Collaborators
Stanford University
Brain Trauma Foundation
United States Department of Defense
Food and Drug Administration (FDA)
U.S. Army Medical Research and Development Command
Department of Health and Human Services
Investigators
Layout table for investigator information
Principal Investigator: Jessica A Little, PhD Stanford University
  Study Documents (Full-Text)

Documents provided by Jamshid Ghajar, Stanford University:

Layout table for additonal information
Responsible Party: Jamshid Ghajar, Clinical Professor of Neurosurgery, Stanford University
ClinicalTrials.gov Identifier: NCT02877732    
Other Study ID Numbers: 20160727
First Posted: August 24, 2016    Key Record Dates
Results First Posted: April 30, 2018
Last Update Posted: May 30, 2018
Last Verified: April 2018
Keywords provided by Jamshid Ghajar, Stanford University:
Concussion
Athletes
Eye-tracking
Vision